VOR

Vor Biopharma Inc.

Insider Trades

NameValueActionPriceCurrent Price
Reprogrammed Interchange LLC10 Percent Owner
$591k284.2k shares
SellAug 26, 2025
$2.08
--
Reprogrammed Interchange LLC10 Percent Owner
$820k387.3k shares
SellAug 25, 2025
$2.12
--
Reprogrammed Interchange LLC10 Percent Owner
$1.6M806.4k shares
SellAug 28, 2025
$2.01
--
Reprogrammed Interchange LLC10 Percent Owner
$1.2M611.6k shares
SellAug 27, 2025
$2.01
--
Reprogrammed Interchange LLC10 Percent Owner
$787k400k shares
SellSep 5, 2025
$1.97
--
Reprogrammed Interchange LLC10 Percent Owner
$874k453k shares
SellSep 4, 2025
$1.93
--

News

globenewswire.comTelitacicept Receives NMPA Approval for the Treatment of Sjögren's Disease in Chinaglobenewswire.comJun 8globenewswire.comTelitacicept Receives NMPA Conditional Approval for the Treatment of IgA Nephropathy in Chinaglobenewswire.comJun 8globenewswire.comVor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)globenewswire.comJun 1globenewswire.comVor Bio to Participate in the 2026 Jefferies Global Healthcare Conferenceglobenewswire.comMay 28globenewswire.comVor Bio Announces Publication of Interim Analysis of TELIGAN, a China Phase 3 Trial of Telitacicept in IgA Nephropathy, in The New England Journal of Medicineglobenewswire.comMay 14